January 18, 2016 by Chain Drug Review
Martin Dempsey, NACDS Annual Meeting, National Association of Chain Drug Stores, Steve Anderson
2016, Issue 01-18-2016, Issues, News
ARLINGTON, Va. — Retired U.S. Army general and former chairman of the Joint Chiefs of Staff Martin Dempsey will speak at the 2016 National Association of Chain Drug Stores’ Annual Meeting on Tuesday, April 19, in Palm Beach, Fla. News of the general’s engagement in the NACDS Annual Meeting follows December’s announcement that former Speaker
January 18, 2016 by Brian Bossetta and Chain Drug Review
free prescription program, Meijer, Nat Love
2016, Issue 01-18-2016, Issues, News
GRAND RAPIDS, Mich. — Meijer Inc. pharmacies marked a milestone recently when the retailer’s free prescription program hit 30 million prescriptions dispensed — 6 million alone in 2015 — since October 2006 when the program launched. The program has saved customers more than $422 million, said vice president of pharmacy Nat Love. “Meijer is a
January 18, 2016 by Scot Meyer and Chain Drug Review
National Association of Chain Drug Stores, RCRA, Resource Conservation and Recovery Act, Retail Industry Leaders Association, RILA, waste management
2016, Issue 01-18-2016, Issues, News
ARLINGTON, Va. — The National Association of Chain Drug Stores has joined other retail trade associations in commenting on proposed updates to the Environmental Protection Agency’s waste management regulations. Those rules could affect the way retailers handle their unsold consumer products and pharmaceuticals. NACDS — together with the Retail Industry Leaders Association (RILA), the Food
January 18, 2016 by Jeffrey Woldt and Chain Drug Review
Affordable Care Act, health insurance, Jeffrey Woldt, Obamacare, Paul Ryan, President Obama, Sylvia Burwell
2016, Issue 01-18-2016, Issues, Leading Headlines, Opinion
Clearly, health care reform will remain a contentious issue during the current presidential election cycle and beyond. The House of Representatives started the new year by voting to gut the Affordable Care Act. Passage of the legislation, by a 240-to-181 margin that closely mirrored the breakdown among parties in the Republican-controlled body, together
January 18, 2016 by David Pinto and Chain Drug Review
chain drug retailing, Christmas selling season, CVS, David Pinto, Rite Aid, Walgreens Boots Alliance, Walgreens-Rite Aid
2016, Issue 01-18-2016, Issues, Opinion
The new year has begun inauspiciously for chain drug retailing, an industry that is still trying to assess the results of the just completed Christmas selling season. By all accounts, December was a month of no great accomplishments, even if it was not the disaster some observers predicted. Now it’s on to 2016, and the
January 6, 2016 by Geoff Walden and Chain Drug Review
$4 generics, Chain Drug Review, health and wellness, Michelle Gloeckler, Pharmacy Innovator of the Year, retail pharmacy, Walmart, Walmart Care Clinics
2016, Featured Articles, Issue 01-04-2016, Issues, Leading Headlines, News, Pharmacy, Retail News
BENTONVILLE, Ark. — Walmart has had a long history of making health care more accessible and affordable. From the launch of $4 generics in 2006 to the recent introduction of Walmart Care Clinics, which promise to have the same kind of impact on pricing in that sector as the earlier program did in pharmacy, the
January 5, 2016 by Jeffrey Woldt and Chain Drug Review
Chain Drug Review, CVS Health, CVS/pharmacy, Judy Sansone, Merchant of the Year
2016, Featured Articles, Issue 01-04-2016, Issues, Leading Headlines, News, Retail News
WOONSOCKET, R.I. — Over the course of the past decade, CVS Health has undergone profound changes, transforming itself from a traditional drug store operator into a health care innovation company. One constant throughout the process has been the rock-solid performance of the front-end retail business to which the company traces its origins. Health and beauty
January 4, 2016 by Chain Drug Review
Chain Drug Review, John Standley, Retailer of the Year, Rite Aid, Stefano Pessina, Walgreens Boots Alliance
2016, Business, Featured Articles, Issue 01-04-2016, Issues, Leading Headlines, News, Retail News
For 2015, the editors of Chain Drug Review have chosen to give the publication’s annual Retailer of the Year honors to two chain drug retail industry leaders: Stefano Pessina, executive vice chairman and CEO of Walgreens Boots Alliance Inc., and the management team at Rite Aid Corp., led by chairman and CEO John Standley. Pessina’s
January 4, 2016 by Geoff Walden and Chain Drug Review
Alex Gourlay, CVS Health, J. Michael Pearson, Larry Merlo, Valeant Pharmaceuticals International, Walgreens
2016, Issue 01-04-2016, Issues, News
DEERFIELD, Ill. — Walgreens and Valeant Pharmaceuticals International Inc. have inked a distribution deal that will cut prices of Valeant prescription products at Walgreens by 10%, and may be extended to independent retail pharmacies. The discount will apply to wholesale list prices and will be phased in over the next six to nine months. The
January 4, 2016 by Geoff Walden and Chain Drug Review
Brian Cornell, CVS Health, Larry Merlo, Target Corp.
2016, Issue 01-04-2016, Issues, News
WOONSOCKET, R.I. — CVS Health Corp. has completed the acquisition of Target Corp.’s pharmacy and clinic businesses, making CVS the No. 1 drug chain by store count and sales. With the closing of the $1.9 billion deal, CVS has picked up Target’s 1,672 pharmacies across 47 states, giving it more than 9,500 prescription counters. Walgreens
January 4, 2016 by Geoff Walden and Chain Drug Review
Federal Trade Commission, John Standley, Rite Aid, Stefano Pessina, Walgreens Boots Alliance
2016, Issue 01-04-2016, Issues, News
CAMP HILL, Pa. — Rite Aid Corp. stockholders will vote next month on the company’s merger with Walgreens Boots Alliance (WBA). Rite Aid has scheduled a February 4 special stockholders meeting for the balloting. Stockholders as of the close of business on December 18 will be eligible to vote. Rite Aid and WBA also announced
January 4, 2016 by Geoff Walden and Chain Drug Review
Analyst Day, Cardinal Health, CVS Health, David Denton, Larry Merlo, Omnicare, Red Oak Sourcing, Target Corp.
2016, Business, Issue 01-04-2016, Issues, News
NEW YORK — CVS Health has raised the midpoint of its earnings outlook for 2016 and reiterated its five-year steady state targets. The company now expects next year’s adjusted earnings per share to range from $5.73 to $5.88, reflecting solid year-over-year growth of 11.25% to 14.25%. The bottom end of the range was increased by
January 4, 2016 by Geoff Walden and Chain Drug Review
Black Friday, holiday retail sales, holiday shopping, National Retail Federation, NPD Group, RetailNext, Shelley Kohan, ShopperTrak
2016, Issue 01-04-2016, Issues, News
NEW YORK — Drug chains were not immune to the shift in holiday shopping away from brick-and-mortar retailing, as sales growth barely exceeded 4%. That was down from last season’s 4.4% advance in holiday retail sales, and well off the 5.4% gain of five years ago. Same-store sales were up 1.8%, virtually unchanged from 2014.
January 4, 2016 by Chain Drug Review
John Boehner, NACDS, NACDS Annual Meeting, National Association of Chain Drug Stores, Steve Anderson
2016, Issue 01-04-2016, Issues, News
ARLINGTON, Va. — John Boehner, the former Speaker of the U.S. House of Representatives, will deliver the keynote address at the 2016 NACDS Annual Meeting. The National Association of Chain Drug Stores said that Boehner (R., Ohio) will speak on Sunday, April 17, during the Business Program at this year’s NACDS Annual Meeting in Palm